Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma

Recent advances in immunotherapy have included inhibition of immune checkpoint proteins in the tumor microenvironment and tumor lysate-based vaccination strategies. We combined these approaches in pet dogs with high-grade glioma. Administration of a synthetic peptide targeting the immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Olin, Michael R., Ampudia-Mesias, Elisabet, Pennell, Christopher A., Sarver, Aaron, Chen, Clark C., Moertel, Christopher L., Hunt, Matthew A., Pluhar, G. Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406711/
https://www.ncbi.nlm.nih.gov/pubmed/30682795
http://dx.doi.org/10.3390/cancers11020137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406711/
https://www.ncbi.nlm.nih.gov/pubmed/30682795
http://dx.doi.org/10.3390/cancers11020137

Ejemplares similares